Literature DB >> 32981962

ECMO Membrane Lung Failure due to Hypertriglyceridemia: A Case Report and Review of the Literature.

Jenelle H Badulak1, Eleanor Curtis2, Eileen M Bulger1.   

Abstract

The deleterious effects of high serum lipid content on the membrane lung (ML) during extracorporeal membrane oxygenation (ECMO) are sparsely documented, and the threshold of lipemia-induced membrane failure is poorly described. We present a case of a patient on venovenous ECMO who developed ML failure after 7 days due to moderate to severe hypertriglyceridemia (700-800 mg/dL). ML failure was exhibited by impaired gas exchange and high transmembrane pressures, and there was notable lipemic layering in the circuit immediately after decannulation. This case demonstrates that in addition to patients with extreme lipemia, ML failure can also occur in patients with moderate to severe hypertriglyceridemia. Hypertriglyceridemia should be suspected in patients with high transmembrane pressures and ML failure not attributable to thrombosis, and these patients may require frequent ML changes if a prolonged ECMO run is required. © Copyright 2020 AMSECT.

Entities:  

Keywords:  ECLS; ECMO; VV ECMO; hypertriglyceridemia; lipemia; lipid; membrane lung failure; oxygenator failure

Mesh:

Year:  2020        PMID: 32981962      PMCID: PMC7499221          DOI: 10.1182/ject-2000026

Source DB:  PubMed          Journal:  J Extra Corpor Technol        ISSN: 0022-1058


  10 in total

1.  Unexplained hemolysis in patients undergoing ECMO: beware of hypertriglyceridemia.

Authors:  A Venado; K Wille; S C Belott; E Diaz-Guzman
Journal:  Perfusion       Date:  2014-10-31       Impact factor: 1.972

2.  Severe Hypertriglyceridemia During Cardiopulmonary Bypass.

Authors:  David Burstedt; J Clint Tippett
Journal:  J Cardiothorac Vasc Anesth       Date:  2019-04-12       Impact factor: 2.628

3.  Lipid emulsion layering in extracorporeal membrane oxygenation circuit.

Authors:  Eric Albrecht; Moira Baeriswyl; Javier Orrit; Kyle Robert Kirkham
Journal:  Intensive Care Med       Date:  2016-07-06       Impact factor: 17.440

4.  High-dose intravenous lipid emulsion affecting successful initiation of continuous venovenous hemofiltration and extracorporeal membrane oxygenation.

Authors:  Jonathan H Sin; Andrew Tom; Alexander Toyoda; Nathalie Roy; Bryan D Hayes
Journal:  Clin Toxicol (Phila)       Date:  2017-07-06       Impact factor: 4.467

5.  Mechanical Failure of Extracorporeal Membrane Oxygenation Induced by Hypertriglyceridemia.

Authors:  Kuk Hui Son; Seok In Lee; Chang-Hyu Choi; Chul Hyun Park
Journal:  Ann Thorac Surg       Date:  2017-07       Impact factor: 4.330

Review 6.  What are the adverse effects associated with the combined use of intravenous lipid emulsion and extracorporeal membrane oxygenation in the poisoned patient?

Authors:  Hwee Min D Lee; John R H Archer; Paul I Dargan; David M Wood
Journal:  Clin Toxicol (Phila)       Date:  2015-01-29       Impact factor: 4.467

7.  Contemporary Oxygenator Design Relative to Hemolysis.

Authors:  Leonie H Venema; Ajay S Sharma; Antoine P Simons; Otto Bekers; Patrick W Weerwind
Journal:  J Extra Corpor Technol       Date:  2014-09

8.  Prolonged Laboratory Interference After Administration of Intravenous Lipid Emulsion Therapy.

Authors:  Kelly Johnson-Arbor; Lauren Salinger; Stephen Luczycki
Journal:  J Med Toxicol       Date:  2015-06

9.  Safety of Propofol for Oxygenator Exchange in Extracorporeal Membrane Oxygenation.

Authors:  Benjamin Hohlfelder; Paul M Szumita; Susan Lagambina; Gerald Weinhouse; Jeremy R Degrado
Journal:  ASAIO J       Date:  2017 Mar/Apr       Impact factor: 2.872

10.  Venlafaxine intoxication with development of takotsubo cardiomyopathy: successful use of extracorporeal life support, intravenous lipid emulsion and CytoSorb®.

Authors:  Ines Schroeder; Michael Zoller; Matthias Angstwurm; Felix Kur; Lorenz Frey
Journal:  Int J Artif Organs       Date:  2017-05-23       Impact factor: 1.595

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.